PMH21 PHARMACY COST IMPACT OF GUIDELINE-RECOMMENDED DOSING OF SECOND GERNERATION ANTIPSYCHOTICS IN SCHIZOPHRENIA
May 1, 2008, 00:00
10.1016/S1098-3015(10)70370-3
https://www.valueinhealthjournal.com/article/S1098-3015(10)70370-3/fulltext
Title :
PMH21 PHARMACY COST IMPACT OF GUIDELINE-RECOMMENDED DOSING OF SECOND GERNERATION ANTIPSYCHOTICS IN SCHIZOPHRENIA
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70370-3&doi=10.1016/S1098-3015(10)70370-3
First page :
Section Title :
Open access? :
No
Section Order :
78